Abstract
Introduction and hypothesis
The goal was to translate into Norwegian, and validate, short versions of the Pelvic Floor Distress Inventory (PFDI-20) and the Pelvic Floor Impact Questionnaire (PFIQ-7) using a sample of women with symptomatic pelvic organ prolapse and pelvic floor dysfunction.
Methods
Modified European Organization for Research and Treatment of Cancer Guidelines were used for translation and cultural adaptation. Of 212 eligible Norwegian women who consented to participate, 205 completed the questionnaires, of whom 50 were retested after 1 – 3 weeks, and 76 were tested 6 months after surgery. Reliability, validity and responsiveness were evaluated. Additionally, interpretability, the smallest detectable change, the standard error of measurement, floor and ceiling effects, and the percentages of missing items are reported.
Results
Reliability ranged from 0.66 to 0.93 and intraclass correlation coefficients from 0.85 to 0.94. Both construct validity and responsiveness were found to be adequate. The responsiveness of the PFDI-20 was further supported by areas under the curve above 0.70. Estimates were lower for the PFIQ-7. The smallest detectable changes at the individual level were 15 – 21 % and 17 – 27 % for the PFDI-20 and PFIQ-7, respectively. The absolute values of the minimal important changes in the total scores were 48 and 47, respectively. No floor or ceiling effects were evident in the distributions of the PFDI-20 and PFIQ-7 total scores.
Conclusions
The translated questionnaires provided adequate reliability, validity and good responsiveness to change. These short versions of the PFDI and PFIQ are robust measuring instruments that will enable symptom severity and health-related quality of life to be evaluated in the Norwegian context.
Similar content being viewed by others
Notes
Based on a sensation of a bulge in the pelvic area (i.e. PFDI-20 )
Based on lower urinary tract symptoms (i.e. PFDI-20 )
Based on bowel symptoms (i.e. PFDI-20) .
References
Abrams P, Andersson KE, Birder L, et al. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010;29:213–240. doi:10.1002/nau.20870.
Nygaard I, Barber MD, Burgio KL, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300:1311–1316. doi:10.1001/jama.300.11.1311.
Barber MD, Kuchibhatla MN, Pieper CF, Bump RC. Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am J Obstet Gynecol. 2001;185:1388–1395. doi:10.1067/mob.2001.118659.
Barber MD, Chen Z, Lukacz E, et al. Further validation of the short form versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ). Neurourol Urodyn. 2011;30:541–546. doi:10.1002/nau.20934.
Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol. 2005;193:103–113. doi:10.1016/j.ajog.2004.12.025.
Abrams P, Cardozo L, Khoury S, Wein A. Incontinence. 5th ed. Paris: Health Publication; 2013.
Teleman P, Stenzelius K, Iorizzo L, Jakobsson U. Validation of the Swedish short forms of the Pelvic Floor Impact Questionnaire (PFIQ-7), Pelvic Floor Distress Inventory (PFDI-20) and Pelvic Organ Prolapse/and Urinary Incontinence Sexual Questionnaire (PISQ-12). Acta Obstet Gynecol Scand. 2011;90:483–487. doi:10.1111/j.1600-0412.2011.01085.x.
Kaplan PB, Sut N, Sut HK. Validation, cultural adaptation and responsiveness of two pelvic-floor-specific quality-of-life questionnaires, PFDI-20 and PFIQ-7, in a Turkish population. Eur J Obstet Gynecol Reprod Biol. 2012;162:229–233. doi:10.1016/j.ejogrb.2012.03.004.
Utomo E, Blok BF, Steensma AB, Korfage IJ. Validation of the Pelvic Floor Distress Inventory (PFDI-20) and Pelvic Floor Impact Questionnaire (PFIQ-7) in a Dutch population. Int Urogynecol J. 2014;25:531–544. doi:10.1007/s00192-013-2263-z.
Dewolf L, Koller M, Velikova G, et al. EORTC Quality of Life Group Translation Procedure. 3rd ed. Brussels: EORTC; 2009.
Dalkey NC. The Delphi method: an experimental study of group opinion. Santa Monica: Rand Corporation; 1969.
Boulkedid R, Abdoul H, Loustau M, Sibony O, Alberti C. Using and reporting the Delphi method for selecting healthcare quality indicators: a systematic review. PLoS One. 2011;6, e20476. doi:10.1371/journal.pone.0020476.
Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25:3186–3191. doi:10.1097/00007632-200012150-00014.
Bump R, Mattiasson A, Bø K, Brubaker L, DeLancey JOL, Klarskov P, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175:10–17. doi:10.1016/S0002-9378(96)70243-0.
Terwee CB, Bot SDM, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34–42. doi:10.1016/j.jclinepi.2006.03.012.
Gandek B, Ware Jr JE, Aaronson NK, et al. Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. J Clin Epidemiol. 1998;51:1149–1158. doi:10.1016/S0895-4356(98)00106-1.
Maruish ME, editor. User’s manual for the SF-36v2 Health Survey. 3rd ed. Lincoln: QualityMetric; 2001.
de Vet HCW, Terwee CB, Mokkink LB, Knol DL. Measurement in medicine: a practical guide. Cambridge: Cambridge University Press; 2011.
Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19:539–549. doi:10.1007/s11136-010-9606-8.
Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63:737–745. doi:10.1016/j.jclinepi.2010.02.006.
Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. 2nd ed. Oxford: Oxford University Press; 1995.
Gelhorn HL, Coyne KS, Sikirica V, Gauld J, Murphy M. Psychometric evaluation of health-related quality-of-life measures after pelvic organ prolapse surgery. Female Pelvic Med Reconstr Surg. 2012;18:221–226. doi:10.1097/SPV.0b013e31825e6707.
Srikrishna S, Robinson D, Cardozo L. Validation of the Patient Global Impression of Improvement (PGI-I) for urogenital prolapse. Int Urogynecol J. 2010;21:523–528. doi:10.1007/s00192-009-1069-5.
Due U, Brostrøm S, Lose G. Validation of the Pelvic Floor Distress Inventory-20 and the Pelvic Floor Impact Questionnaire-7 in Danish women with pelvic organ prolapse. Acta Obstet Gynecol Scand. 2013;92:1041–1048. doi:10.1111/aogs.12189.
Rogers RG, Rockwood TH, Constantine ML, et al. A new measure of sexual function in women with pelvic floor disorders (PFD): the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR). Int Urogynecol J. 2013;24:1091–1103. doi:10.1007/s00192-012-2020-8.
Handa VL, Barber MD, Young SB, et al. Paper versus web-based administration of the Pelvic Floor Distress Inventory 20 and Pelvic Floor Impact Questionnaire 7. Int Urogynecol J. 2008;19:1331–1335. doi:10.1007/s00192-008-0651-6.
Acknowledgements
The authors acknowledge the patients and expert panel who provided input to this study; the Department of Obstetrics and Gynaecology, Akershus University Hospital, for patient recruitment; A.S. Midthaug and K.A. Askestad for assistance with data collection; M. Solberg for assistance with data entry; Dr. W. Mokkink for assistance with editing; Drs. T. Øresland, K. Bø, H.C.W. de Vet and S. Saga for assistance with protocol development; and M.D. Barber for permission to translate the PFDI-20 and PFIQ-7 and assistance in the translation process.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study was funded by the Division of Surgery, Akershus University Hospital, and the Strategic Research Foundation (Strategiske Forskningsmidler), Akershus University Hospital. The Strategic Research Foundation was not involved in the design, conduct, analysis or interpretation of the study, or the review or approval of the manuscript.
Conflicts of interest
None.
Appendices
Appendix 1: Spørreskjema om bekkenbunnsplager - skjema PFDI-20
Veiledning: Vennligst svar på alle spørsmålene i spørreskjemaet. Spørsmålene dreier seg om hvorvidt du har visse symptomer i tarmen, blæren eller bekkenregionen, og i så fall hvor mye de plager deg. Svar på spørsmålene ved å krysse av i den eller de boksene som passer for deg. Hvis du er usikker på hva du skal svare, svarer du så godt du kan. Vær snill og svar på spørsmålene ut fra de symptomer du har hatt gjennom de siste tre månedene.
Appendix 2: Spørreskjema om bekkenbunnsplager og innvirkning på dagliglivet - skjema PFIQ-7
Veiledning: Noen kvinner opplever at symptomer fra blæren, endetarmen eller skjeden påvirker deres gjøremål, forhold og følelser. For hvert av spørsmålene ber vi deg krysse av for svaret som best beskriver hvordan dine gjøremål, forhold eller følelser har blitt påvirket av symptomer eller plager fra blære, endetarm eller skjede de tre siste månedene. Husk å krysse av i alle de tre kolonnene for hvert spørsmål.
Rights and permissions
About this article
Cite this article
Teig, C.J., Grotle, M., Bond, M.J. et al. Norwegian translation, and validation, of the Pelvic Floor Distress Inventory (PFDI-20) and the Pelvic Floor Impact Questionnaire (PFIQ-7). Int Urogynecol J 28, 1005–1017 (2017). https://doi.org/10.1007/s00192-016-3209-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-016-3209-z